Transcatheter Aortic Valve Implantation (TAVI)
Real-world results
The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.
This multicenter, prospective, single-arm, observational post-market study evaluated the safety and performance of the Evolut™ R system in a routine hospital setting.
1 year hemodynamic data
30-day procedural outcomes
ADVANCE is a multicenter, prospective, single-arm, observational study to evaluate safety and performance of the CoreValve™ system in a routine clinical setting.
Study Status/Duration: 5-year outcomes reported/5-year follow-up
Sample Size: N = 1,015
Devices: CoreValve, TAV
Review the latest data supporting the Evolut™ platform.
Discover our procedural guidance and outcomes you can expect from the Evolut™ platform.
Medtronic Academy offers a wide range of resources for the Evolut™ TAVI platform.
™* Third-party brands are trademarks of their respective owners.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.